23/01/2026 14:50
UBS raised the target price for RemeGen (09995) to HKD120 from HKD63.8 and upgraded the rating to "buy" from "neutral".
The research house said it is positive on the recent partnership with AbbVie.
【你點睇？】美國擬向歐洲八國加徵關稅，直至成功購買格陵蘭，歐洲領袖表明不可接受。你認為美國此舉會否導致美歐關係破裂？ ► 立即投票
上一篇新聞︰23/01/2026 16:06 {I-bank focus}HSBC raises CTF Services (00659) to HKD10.1
下一篇新聞︰22/01/2026 16:03 {I-bank focus}Macquarie raises Chow Tai Fook to HKD19.8
22/01/2026 14:45 {I-bank focus}UBS raises ASMPT (00522) to HKD135
21/01/2026 16:01 {I-bank focus}Daiwa lowers Tencent (00700) to HKD725
20/01/2026 16:02 {I-bank focus}Citi lowers Bud APAC (01876) to HKD11.4
19/01/2026 16:01 {I-bank focus}Citi raises WH Group (00288) to HKD9.5
19/01/2026 14:34 {I-bank focus}Citi raises Conant Optical (02276) to HKD70
